INDIAGLYCO India Glycols Q2 FY25 results (Jul–Sep 2024) and concall
India Glycols reported a strong Q2 and H1 FY25, driven by robust growth in biofuels and potable spirits segments. While overall EBITDA margins saw a slight dip, the company emphasized strategic shifts towards higher-value specialty chemicals and cost reduction initiatives. The management expressed confidence in the long-term growth trajectory, particularly in new business areas and the government's ethanol blending program, despite acknowledging some margin pressures in specific segments.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 |
|---|---|
| Revenue | 961 |
| EBITDA | 116 |
| Net profit | 39 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
